Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colorectal Neoplasms × Abiraterone Acetate × Clear all

Sponsor

Conditions

Prostatic Neoplasms 67 Neoplasm Metastasis 6 Prostatic Neoplasms, Castration-Resistant 4 Metastatic Castration-resistant Prostate Cancer 4 Neoplasms 3 Prostate Cancer Metastatic 2 Metastatic Castration Resistant Prostate Cancer 2 Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Metastatic Castration-sensitive Prostate Cancer 1 Hyperaldosteronism 1 Castration-resistant Prostate Cancer 1 Castrate-resistant Prostate Cancer 1 Adenocarcinoma 1

Interventions

Bevacizumab 112 Fluorouracil 97 Oxaliplatin 96 Leucovorin 95 Irinotecan 85 Capecitabine 73 Cetuximab 63 Panitumumab 42 pembrolizumab 36 regorafenib 28 Nivolumab 22 IFL protocol 21 Folfox protocol 21 trifluridine tipiracil drug combination 14 Radiotherapy 13 durvalumab 11 Gemcitabine 10 Celecoxib 9 tremelimumab 7 binimetinib 7 aflibercept 7 Drug Therapy 7 Disulfides 7 Cyclophosphamide 7 Trifluridine 6 Trastuzumab 6 Sunitinib 6 Immunoglobulin G 6 Colonoscopy 6 130-nm albumin-bound paclitaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡